Joseph K. Belanoff, Chief Executive Officer at CORCEPT THERAPEUTICS INC (CORT), sold 40,000 shares at $70.52 ($2.8M) on 2025-09-02, disclosed to the SEC on 2025-09-04.
Scheduled sale ($2.8M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.52 | 39,300 | $2.8M | 98.2% |
| 2 | $71.01 | 700 | $50K | 1.8% |
| Total | $70.53 avg | 40,000 | $2.8M | 100% |
| Filing → |
| CORT | SELL | 2026-03-27 | $2.6M | — | Filing → |
| CORT | SELL | 2025-12-03 | $3.2M | — | Filing → |
| CORT | SELL | 2025-11-05 | $4.9M | — | Filing → |